This course will dig into first principles and physiological understanding of glaucoma in order to best understand and apply current management strategies including medication, SLT, sustained release options, and surgical procedures. Advances in understanding of pathophysiology, genetics, and the goal of development of disease-modifying therapies are highlighted.
Almost 1100 attended our event and we received amazing feedback!
Feedback from anonymous survey:
I really liked the speaker. She was very well spoken and easy to understand.
Well organized and coherant presentation.
Great and knowledgeable speaker. She broke down diagnosis and treatment in digestible and easy to absorb ways.
Doc you are awesome! I learned so much from you tonight. Thank you.
Excellent speaker, would love to attend more of her educational class!
Dr. Steen is always a pleasure to listen to- she is well spoken, knowledgeable & conveys information in an easy to digest manner.
Great information! High yield stuff.
Awesome and intelligent speaker. Bonus points for being female.
Dr. Steen is an excellent speaker. Very knowledgeable!
One of the best CE talks I’ve heard. Very informative with clear communication! Well done.
One of the best WOO speakers. I appreciate how clear and easy to understand her explanations are.
Speaker is very good at explaining what to look for and why glaucoma affects certain individuals. Good updated info too!
Speaker: Dr. Jessica Steen
Moderator: Dr. Carolyn Majcher
COPE ID: 98056-GL
Category: Glaucoma
This event is COPE approved for 1 hour of CE credit.
Allergan is now AbbVie—Your Vision. Our Mission.
At AbbVie, we set our sights on a future where vision lasts a lifetime. With a legacy of more than 75 years in eye care, we are focused on preserving and protecting vision for patients around the world. We treat conditions from the front to the back of the eye, including glaucoma, ocular surface disease, and retinal diseases.